Day 2 Full Agenda
Tuesday, May 5, 2026
8:30 AM
Epidemiology of PTE - Clinical Session
Introduction: Severn B. Churn, PhD, NIH-NINDS, Session Moderator
| "Epidemiology of Post-Traumatic Epilepsy" | Andrea Schneider, MD, PhD, University of Pennsylvania |
| "Beyond the Seizures: Addressing the High Burden of Premature Mortality in Post-Traumatic Epilepsy" | Mary Jo Pugh PhD, RN, University of Utah |
| "AI in post-traumatic epilepsy" | Matthew Pease, MD, Indiana University |
| Announcement April 1st | Early-Stage Investigator |
9:45 AM - Break
10:15 AM
Clinical risk factors for PTE (Clinical Session, part 2)
Introduction: Alexandra Ulyanova, University of Pennsylvania, Session Moderator
| "Quantitative EEG and Imaging Biomarkers of Post-Traumatic Epilepsy" | Jennifer A. Kim, MD, PhD, Yale University |
| "Leveraging Biomarkers for PTE Risk Prediction" | Amy K. Wagner, MD, University of Pittsburgh |
| "It is all written in the waves" | Edilberto Amorim, MD, University of California, San Francisco |
| Announcement April 1st | Early Career Investigator TBD |
11:50 AM - Lunch and Poster Session
2:30 PM
The importance of Common Data Elements for PTE research
Severn B. Churn, PhD, NINDS
2:50 PM
Clinical risk factors for PTE (Clinical Session, part 3)
Introduction: Pavel Klein (George Washington University), Session Moderator
| "Informatics-Driven Approaches to PTE: Linking Acute EEG, MRI Lesion Phenotypes, and Longitudinal Outcomes" | Dominique Duncan, PhD, University of Pennsylvania |
| "Neuroimaging of post-traumatic epilepsy" | James J Gugger, MD, PharmD, University of Rochester |
| "Post-Traumatic Epilepsy as Model of Epileptogenesis: Novel Biomarkers and Therapeutics" | James Castellano, MD, PhD, University of Pittsburgh |
| Early-Stage Investigator |
4:20 PM - Break
4:30 PM
Discussion and Wrap-up of Day 2
What are the ideal patient populations to recruit in early phase clinical trials of anti-epileptogenic therapies for PTE?
Moderator and Discussants: Amy Wagner, MaryJo Pugh
5:00 PM